CA AB1460

Prohibits prescription drug manufacturers from engaging in discriminatory practices that restrict qualifying nonhospital 340B community clinics from purchasing or receiving discounted drugs when using contract pharmacies to dispense medications to eligible patients

Defines discriminatory practices to include limiting clinics to one contract pharmacy, restricting use of contract pharmacies if clinics have in-house pharmacies, imposing distance limitations on shipping to patients, or limiting which medications qualify for discounts

Requires qualifying nonhospital 340B community clinics to annually conduct independent audits of contract pharmacies, report to federal Health Resources and Services Administration (HRSA) how 340B savings support patient care, and recertify their covered entity status

Permits manufacturers to request deidentified claim data (invoice numbers, unique identifiers, coding) annually to investigate duplicate discounts or diversion, but prohibits withholding 340B discounts while data is being reconciled

Applies to community clinics licensed under Health and Safety Code Section 1204, city/county-operated clinics exempt from licensure, intermittent clinics, and rural health clinics that participate in the federal 340B drug pricing program